Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 5
2005 2
2006 2
2007 1
2008 2
2009 2
2010 3
2011 1
2012 4
2013 7
2014 6
2015 4
2016 4
2017 8
2018 3
2019 3
2020 4
2021 6
2022 5
2023 4
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES.
Steg PG, Szarek M, Jukema JW, Bhatt DL, Bittner VA, Diaz R, Fazio S, Garon G, Goodman SG, Harrington RA, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators. Steg PG, et al. Circulation. 2025 Apr 8;151(14):1047-1050. doi: 10.1161/CIRCULATIONAHA.124.071269. Epub 2025 Apr 7. Circulation. 2025. PMID: 40193536 Free article. No abstract available.
Lassa fever outbreaks, mathematical models, and disease parameters: a systematic review and meta-analysis.
Doohan P, Jorgensen D, Naidoo TM, McCain K, Hicks JT, McCabe R, Bhatia S, Charniga K, Cuomo-Dannenburg G, Hamlet A, Nash RK, Nikitin D, Rawson T, Sheppard RJ, Unwin HJT, van Elsland S, Cori A, Morgenstern C, Imai-Eaton N; Pathogen Epidemiology Review Group. Doohan P, et al. Lancet Glob Health. 2024 Dec;12(12):e1962-e1972. doi: 10.1016/S2214-109X(24)00379-6. Lancet Glob Health. 2024. PMID: 39577970 Free article.
Multiplatform web app (My Way Up) plus motivational interviewing for improving treatment retention in patients with onset of alcohol-related liver disease and alcohol use disorder - an example of participatory research.
Caballeria E, Balcells-Oliveró M, Bataller R, Bruguera P, Cabrera N, Estruch A, Freixa N, Garcia-Pañella Ó, Graell M, Gratacós-Gines J, Guzman P, Hernández-Rubio A, Lligoña A, Pérez-Guasch M, Pons-Cabrera MT, Pose E, Zuluaga P, López-Pelayo H. Caballeria E, et al. Among authors: guzman p. Digit Health. 2024 May 6;10:20552076241242787. doi: 10.1177/20552076241242787. eCollection 2024 Jan-Dec. Digit Health. 2024. PMID: 38715972 Free PMC article.
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Manvelian G, Pordy R, Poulouin Y, Stipek W, Garon G, Schwartz GG; ODYSSEY OUTCOMES Investigators. Goodman SG, et al. Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):342-352. doi: 10.1093/ehjcvp/pvae025. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38658193 Free PMC article. Review.
Retraction Note: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.
Flaqué MCD, Galigniana NM, Béguelin W, Vicario R, Proietti CJ, Russo RC, Rivas MA, Tkach M, Guzmán P, Roa JC, Maronna E, Pineda V, Muñoz S, Mercogliano MF, Charreau EH, Yankilevich P, Schillaci R, Elizalde PV. Flaqué MCD, et al. Among authors: guzman p. Breast Cancer Res. 2023 Nov 2;25(1):133. doi: 10.1186/s13058-023-01735-z. Breast Cancer Res. 2023. PMID: 37919764 Free PMC article. No abstract available.
Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study.
Angulo JC, Ciria Santos JP, Gómez-Caamaño A, Poza de Celis R, González Sala JL, García Garzón JM, Galán-Llopis JA, Pérez Sampietro M, Perrot V, Planas Morin J; ANARESISTANCE study group. Angulo JC, et al. World J Urol. 2022 Oct;40(10):2459-2466. doi: 10.1007/s00345-022-04108-x. Epub 2022 Sep 4. World J Urol. 2022. PMID: 36057895 Free PMC article.
79 results